ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Aug 17, 2022 12:23 JST
免税第一股中国中免获机构追捧已超购 政策利好备受瞩目
香港, Aug 17, 2022 - (ACN Newswire) - 免税行业龙头股中国中免(股份代号:1880)于2022年8月15日公开招股,招股期至18日,每股介乎143.50港元至165.50港元,每手100股,入场费约16716.8港元,集资最多170.1亿港元,为目前本港今年最大IPO。公司不仅引入9家基石投资者长线支持,传闻首日国际配售开簿一小时即获足额认购,目前获高倍数认购,如此实属罕见,据闻国际顶级长线投资机构及中资意见领袖机构均积极下单,看好其长线投资价值。
中金公司、瑞银集团为中国中免联席保荐人,并获基石投资者认购约62.38亿元股份。此次募集资金主要用于巩固内地渠道、拓展海外渠道,以及进行市场推广,并改善供应链效率、升级信息技术系统。
中国作为全球重要的旅游零售商品市场,2021年市场规模达人民币808亿,其中,免税商品的销售已成为中国旅游零售市场日益重要的一环,于2021年占中国旅游零售市场的59.5%,预期2026年将达至73.8%。2021年,中国中免蝉联全球旅游零售行业市场榜首,占全球份额24.6%,力证龙头地位。
目前中国中免是内地唯一覆盖全免税销售的零售运营商,拥有先天稀缺对标性,核心利润能力领跑市场。收入由2019年约人民币480.13亿元增长至2021年约人民币676.76亿元,复合年增长率达到18.7%。2019年至2021年间,中国中免的年净利润从约人民币54.71亿元增长至约人民币124.41亿元,复合年增长率达到50.8%。
2020年,政府部门进一步提高离岛免税额度,计划将海南省建设为自由贸易港及国际旅游消费中心。中国中免在海南离岛免税市场占有超90%份额,拥有三亚国际免税城和海口在建的最大旅游零售综合体,市场前景广阔。在海南免税商品强劲需求以及政策红利带动下,中国中免海南离岛店的收入由2019年的人民币132.5亿元增加至2021年的人民币470.6亿元,增幅达255.1%。加之海南自贸港建设方案的提出,对港内实质经营性企业实行税收优惠,中国中免旗下的6家公司可以享受15%的优惠税率,将持续优化公司净利表现。
得益于消费回流趋势以及免税政策显著扩容升级,红利加速释放,免税行业进入全新发展阶段。中国中免赴港上市是其实现国际化和确保稳定发展的重要举措。港股上市能为公司搭建国际资本运作平台,加速融入国际资本市场,获得全球化的渠道及产业链资源,加强其核心业务,巩固国内渠道,拓展海外渠道,充分利用优质销售渠道和市场资源的优势,升级现有供应链和上游采购体系,进一步强化包括运营管理、采购、物流配送、信息管理及数字化、市场营销等核心能力建设。未来,中国中免以发展自身优势稳固免税龙头地位,抓住市场行业变化趋势,提升全球市场竞争力,创造投资价值最大化。
Sectors: Daily Finance
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
MHI Commends Outstanding Examples of Implementing its New Management Policy "ITO"
Mar 18, 2026 13:09 JST
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41 JST
TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025
Mar 17, 2026 21:00 JST
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
Mar 17, 2026 19:49 JST
Successful Flight Demonstration of Mission Autonomy Developed for Use in Unmanned Aerial Vehicles
Mar 17, 2026 14:11 JST
The University of Tokyo and NEC conclude a Strategic Collaboration Agreement to promote a prosperous society where people and AI succeed together
Mar 17, 2026 12:34 JST
Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)
Mar 16, 2026 16:20 JST
Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management
Mar 16, 2026 12:55 JST
FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation
Mar 16, 2026 10:25 JST
Mitsubishi Shipbuilding Completes Handover of WAKASHIO MARU Training Ship for National Institute of Technology, Toyama College
Mar 13, 2026 16:01 JST
Mitsubishi Heavy Industries to Introduce 10MW-Class Centrifugal Chiller for Next-Generation AI Data Centers in North America
Mar 13, 2026 14:10 JST
Spritzer Sparkling's 'Serikan Raya, Sparkling-kan Suasana' Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist
Mar 13, 2026 12:45 JST
Hitachi to deliver the world's first 550 kV gas-insulated switchgear in which the entire equipment is SF(6)-free to Chubu Electric Power Grid
Mar 12, 2026 19:40 JST
Honda Announces Losses Associated with Reassessment of Automobile Electrification Strategy; Revision to Forecast for Consolidated Financial Results; and Future Direction
Mar 12, 2026 19:02 JST
Japantastics Introduces the World of Kodaimoji, Bringing Ancient Characters into Modern Spaces
Mar 12, 2026 19:00 JST
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
Mar 12, 2026 17:21 JST
NEC Develops Physical AI That Anticipates Human Movement and Psychological States
Mar 12, 2026 16:41 JST
NEC and The University of Tokyo calculate carbon accumulation rates in Malaysian national park with a 9.4% margin of error
Mar 12, 2026 12:02 JST
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis
Mar 11, 2026 20:15 JST
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting
Mar 11, 2026 12:07 JST
More Latest Release >>